Aperam (OTCMKTS:APEMY – Get Free Report)’s share price gapped down prior to trading on Friday . The stock had previously closed at $56.80, but opened at $52.73. Aperam shares last traded at $52.68, with a volume of 416 shares trading hands.
Analysts Set New Price Targets
Several equities research analysts have commented on the stock. Citigroup reissued a “neutral” rating on shares of Aperam in a research report on Wednesday, May 20th. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating on shares of Aperam in a report on Friday, September 4th. Zacks Research raised Aperam from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, July 15th. Finally, BNP Paribas Exane downgraded Aperam from a “hold” rating to a “strong sell” rating in a research note on Wednesday, July 8th. One research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy”.
Check Out Our Latest Stock Report on Aperam
Aperam Trading Down 7.3%
About Aperam
Aperam SA is a Luxembourg-based producer of stainless, specialty and electrical steels. The company manufactures a broad range of flat and long stainless steel products, including coils, sheets, plates, bars and wires, serving applications in sectors such as automotive, construction, engineering, energy, food processing and household appliances.
Aperam also produces nickel alloys and other specialty materials designed for demanding industrial environments. Through its services and solutions activities, the company provides processing, finishing, distribution and related support for steel products.
Recommended Stories
- Five stocks we like better than Aperam
- Block Makes a Federal Trust Bank Move That Could Reshape Its Fintech Model
- Kroger’s Textbook Entry for Buy-and-Hold Investors
- AST SpaceMobile Looks to Extend Its 30-Day FCC Satellite Testing Window
- Amgen Drops 10% on a Trial It Didn’t Even Run
Receive News & Ratings for Aperam Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aperam and related companies with MarketBeat.com's FREE daily email newsletter.
